Latest News and Press Releases
Want to stay updated on the latest news?
-
Westford, July 02, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the biosimilars market will attain a value of USD 92 billion by 2031, with a CAGR of 16.4% during the forecast period (2024-2031)....
-
New York, United States , Nov. 01, 2022 (GLOBE NEWSWIRE) -- The Global Biosimilars Market Size was valued at USD 17.6 Billion in 2021, the market is projected to grow USD 56.40 Billion in 2030, at a...
-
New York, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Research Nester has published a detailed market report on ‘Global Biosimilars Market’ for the forecast period, i.e. 2023 – 2033 which includes the...
-
New York, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Rapid growth of the pharmaceutical realm and higher prices of existing biological drugs are likely to foster attractive growth avenues in the biosimilars...
-
WASHINGTON, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Biosimilars Market finds that the increasing chronic diseases and rising cost effectiveness of...
-
Chicago, July 26, 2022 (GLOBE NEWSWIRE) -- Biosimilars Market size is projected to reach USD 44.7 billion by 2026 from USD 15.6 billion in 2021, at a CAGR of 23.5% during the forecast period of 2021...
-
With 21.5% CAGR, Global Biosimilars Market Size Worth USD 87.12 Billion in 2030, Growth Plus Reports
Pune, July 05, 2022 (GLOBE NEWSWIRE) -- The Global Biosimilars Market is expected to clock US$ ~87.12 billion by 2030 due to a robust pipeline for biosimilars and increasing demand for biosimilars....
-
WASHINGTON, Feb. 14, 2022 (GLOBE NEWSWIRE) -- The Global Biosimilars Market size is expected to reach USD 103.94 Billion by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 25.6% during the...
-
Pune, Aug. 16, 2019 (GLOBE NEWSWIRE) -- The U.S. Biosimilars Market will gain momentum from the increasing government support to adopt biosimilars in the healthcare sectors. According to a report by...
-
NEW YORK, April 15, 2019 (GLOBE NEWSWIRE) -- According to the market research report published by P&S Intelligence, biosimilars market is expected to generate $26.7 billion revenue by 2024,...